— Know what they know.
Not Investment Advice
Also trades as: XVIVO.ST (STO) · $vol 1M · 0RKL.L (LSE) · $vol 0M · XVIPF (OTC) · $vol 0M

XVIPY OTC

Xvivo Perfusion AB (publ)
1W: -13.2% 1M: -29.1% YTD: -15.9%
$5.50
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 41 · $693.0M mcap · 40M float · 0.0014% daily turnover · Short 82% of daily vol

Balance Sheet Trends

Total Assets
$2.4B +9.4% ▲
5Y CAGR: +30.5%
Total Liabilities
$246M -1.8% ▼
5Y CAGR: +34.0%
Shareholders Equity
$2.2B +10.9% ▲
5Y CAGR: +30.2%
Cash & Investments
$416M -23.9% ▼
5Y CAGR: +21.2%
Total Debt
$34M +8.3% ▲
5Y CAGR: +43.7%
Net Debt
-$381M +25.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$353M$399M$247M$546M$416M
Short-Term Investments$0$0$0$300K$0
Cash & ST Investments$353M$399M$247M$546M$416M
Net Receivables$44M$60M$100M$98M$117M
Inventory$59M$78M$107M$142M$227M
Other Current Assets$4M$12M$10M$20M$24M
Total Current Assets$463M$548M$468M$826M$813M
Property, Plant & Equip.$21M$26M$48M$98M$149M
Goodwill & Intangibles$625M$925M$1.2B$1.2B$731M
Long-Term Investments$754K$1M$411K$582K$898K
Other Non-Current Assets$1K$0$0$0$709M
Total Non-Current Assets$687M$995M$1.3B$1.4B$1.6B
Total Assets$1.2B$1.5B$1.7B$2.2B$2.4B
— Liabilities —
Accounts Payable$14M$21M$38M$36M$39M
Short-Term Debt-$49M$10M$0$0$0
Deferred Revenue$49M$47M$3M$0$0
Other Current Liabilities-$44M$42M$35M$31M$42M
Total Current Liabilities$72M$105M$135M$134M$178M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$40M$125M$138M$66M$45M
Total Non-Current Liabilities$70M$153M$168M$116M$68M
Total Liabilities$142M$257M$303M$251M$246M
— Equity —
Common Stock$734K$754K$762K$805K$805K
Retained Earnings$1M$9M$28M$120M$292M
Accumulated OCI-$182K$22M$88M$0$92M
Total Stockholders Equity$1.0B$1.3B$1.4B$1.9B$2.2B
Total Liabilities & Equity$1.2B$1.5B$1.7B$2.2B$2.4B
— Key Metrics —
Total Debt$7M$6M$10M$31M$34M
Net Debt-$346M-$393M-$237M-$514M-$381M
Total Investments$754K$1M$411K$882K$898K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms